Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.

Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, Guzman-Beltran S, Manjarrez ME, Muñoz-Torrico M, Garcia-Garcia L, Sada E, Torres M.

BMC Infect Dis. 2013 Nov 15;13:544. doi: 10.1186/1471-2334-13-544.

PMID:
24238117
[PubMed - in process]
Free PMC Article
2.

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI.

Emerg Infect Dis. 2013 Mar;19(3):439-48. doi: 10.3201/eid1903.120394.

PMID:
23622679
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A novel synthetic receptor-based immunoassay for influenza vaccine quantification.

Hashem AM, Gravel C, Farnsworth A, Zou W, Lemieux M, Xu K, Li C, Wang J, Goneau MF, Merziotis M, He R, Gilbert M, Li X.

PLoS One. 2013;8(2):e55428. doi: 10.1371/journal.pone.0055428. Epub 2013 Feb 12.

PMID:
23424631
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.

Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, Halpert MM, Air GM.

PLoS One. 2012;7(12):e50830. doi: 10.1371/journal.pone.0050830. Epub 2012 Dec 11.

PMID:
23239987
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age.

Vesikari T, Pepin S, Kusters I, Hoffenbach A, Denis M.

Hum Vaccin Immunother. 2012 Sep;8(9):1283-92. doi: 10.4161/hv.21265. Epub 2012 Aug 21.

PMID:
22906943
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.

Flynn PM, Nachman S, Muresan P, Fenton T, Spector SA, Cunningham CK, Pass R, Yogev R, Burchett S, Heckman B, Bloom A, Utech LJ, Anthony P, Petzold E, Levy W, Siberry GK, Ebiasah R, Miller J, Handelsman E, Weinberg A; IMPAACT P1088 Team.

J Infect Dis. 2012 Aug 1;206(3):421-30. doi: 10.1093/infdis/jis360. Epub 2012 May 21. Erratum in: J Infect Dis. 2012 Dec 15;206(12):1951.

PMID:
22615311
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Broadbent AJ, Subbarao K.

Curr Opin Virol. 2011 Oct;1(4):254-62. doi: 10.1016/j.coviro.2011.08.002. Review.

PMID:
22125588
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.

Miraglia JL, Abdala E, Hoff PM, Luiz AM, Oliveira DS, Saad CG, Laurindo IM, Viso AT, Tayra A, Pierrotti LC, Azevedo LS, Campos LM, Aikawa NE, Timenetsky Mdo C, Luna E, Cardoso MR, Guedes Jda S, Raw I, Kalil J, Precioso AR.

PLoS One. 2011;6(11):e27214. doi: 10.1371/journal.pone.0027214. Epub 2011 Nov 8.

PMID:
22087267
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.

Manzoli L, De Vito C, Salanti G, D'Addario M, Villari P, Ioannidis JP.

PLoS One. 2011;6(9):e24384. doi: 10.1371/journal.pone.0024384. Epub 2011 Sep 6.

PMID:
21915319
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

PMID:
21573005
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk